Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.

MLA

Chen, Wen-Jie, et al. “Plasma Epstein-Barr Virus DNA and Risk of Nasopharyngeal Carcinoma in a Prospective Seropositive Population.” BMC Cancer, vol. 21, no. 1, June 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12885-021-08408-0.

APA

Chen, W.-J., Xu, W.-N., Wang, H.-Y., Chen, X.-X., Li, X.-Q., Xie, S.-H., Lin, D.-F., & Cao, S.-M. (2021). Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population. BMC Cancer, 21(1), 1–8. https://doi.org/10.1186/s12885-021-08408-0

Chicago

Chen, Wen-Jie, Wen-Na Xu, Hai-Yun Wang, Xiao-Xia Chen, Xue-Qi Li, Shang-Hang Xie, Dong-Feng Lin, and Su-Mei Cao. 2021. “Plasma Epstein-Barr Virus DNA and Risk of Nasopharyngeal Carcinoma in a Prospective Seropositive Population.” BMC Cancer 21 (1): 1–8. doi:10.1186/s12885-021-08408-0.